Drugs / Risperidone microspheres
last change Jan 2011 re-read 3 minutes ago

Risperidone microspheres

Developed for
schizoaffective disorder · schizophrenia
Investigated by
National Institute of Mental Health (NIMH) · Northwell Health

Trials 1

2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 4 NCT00330863 May 2006 → Jan 2011 schizoaffective disorder, schizophrenia Northwell Health Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Risperidone microspheres ClinicalTrials.gov intervention name — accepted as the source's own label NCT00330863 ↗
Route Other “Participants assigned to receive long-acting injectable risperidone” NCT00330863 ↗